Selecting First-Line Treatment for Chronic Lymphocytic Leukemia (CLL)

2 Views
administrator
administrator
07/08/23

Moderator Myron Czuczman, MD, leads experts in a discussion about selecting first-line therapy for varied subgroups with CLL, and recognizing the shift from the traditional chemotherapy regimens to the incorporation of newly approved anti-CD20 antibodies.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next